[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2004, 30(2) 123-125 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||
����-10��������� | |||||||||||||||||||||||||||||||||||||||||||||
����, ����ƽ | |||||||||||||||||||||||||||||||||||||||||||||
���пƼ���ѧͬ��ҽѧԺ����ͬ��ҽԺƤ���Բ���, �人 430030 | |||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
����-10��Ϊһ��Th2��ϸ������,���ж�������ѧ����.����-10���������Ⱦ�����Ե�������,�����û���ΪӰ��Th1/Th2��Ӧƽ��;����������ϸ������;����һ�������ϳ��Լ��µ�������-��ˮƽ. | |||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� ����-10 ������� | |||||||||||||||||||||||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||||||||||||||||||||||
Keywords: | |||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2003-06-03 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||
������Ŀ: | |||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||
[1] Keystone E, Wherry J, Grint P. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am,1998,24(3):629-639. [2] Lusiak M, Podwinska J. Interleukin 10 and its role in the regulation of the cell-mediated immune response in syphilis. Arch Immunol Ther Exp(Warsz),2001,49(6):417-421. [3] Akdis CA, Blaser K. Mechanisms of interlenkin-10-mediated immune suppression. Immunology, 2001, 103(2):131-136. [4] Namla SK, Cutler D, Grint P. Immunomodulation of Crohn's disease by interleukin-10. Agents Actions Suppl, 1998, 49:57-65. [5] Go NF, Castle BE, Barrett R, et al. Interleukin 10, a novel B cell stimulatory factor:unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med, 1990, 172(6):1625-1631. [6] Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology, 2001, 103(2):131-136. [7] Steele C, Fidel PL Jr. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun, 2002, 70(2):577-583. [8] Lacraz S, Nicod LP, Chicheportiche R, et al. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest, 1995, 96(5):2304-2310. [9] Fidel PL Jr. Immunity to Candida. Oral Dis, 2002, 8(Suppl 2):69-75. [10] Montagnoli C, Bacci A, Bozza S, et al. B7/CD28-dependent CD4+ CD25+ regulatory T cells are essential components of the memoryprotective immunity to Candida albicans. J Immunol, 2002, 169(11):6298-6308. [11] Tonnetti L, Spaccapelo R, Cenci E, et al. Interleukin-4 and-10exacerbate candidiasis in mice. Eur J Immunol, 1995, 25(6):1559-1565. [12] Del Sero G, Mencacci A, Cenci E, et al. Antifungal type 1 responses are upregulated in IL10-deficient mice. Microbes Infect, 1999, 1(14):1169-1180. [13] Romani L, Mencacci A, Cenci E,et al. An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J Immunol, 1997, 158(5):2356-2362. [14] Vazquez-Torres A, Jones-Carson J, Wagner RD, et al. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis.Infect Immun, 1999, 67(2):670-674. [15] Laichalk LL, Danforth JM, Standiford TJ. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol Med Microbiol, 1996, 15(4):181-187. [16] Mencacci A, Montagnoli C, Bacci A,et al. CDS0+ Gr1+ myeloid cells inhibit development of antifungal Thl immunity in mice with candidiasis. J Immunol, 2002, 169(6):3180-3190. [17] Romani L, Puccetti P, Bistoni F. Biological role of Th cell subsets in candidiasis. Chem Immunol, 1996, 63:115-137. [18] Cenci E, Romani L, Mencacci A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol, 1993, 23(5):1034-1038. [19] Carvalho LP, Bacellar O, Neves N, et al. Downregulation of IFNgamma production in patients with recurrent vaginal candidiasis. J Allergy Clin Immunol, 2002, 109(1):102-105. [20] Tavares D, Ferreira P, Arala-Chaves M. Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J Infect Dis, 2000, 182(1):266-273. |
|||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |